VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Patient responses to CAR-T therapy and factors that may influence these responses

Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, shares some insights into patient responses to CAR-T therapy, and further discusses factors that may influence these responses, including high-risk features and previous exposure to anti-BCMA therapy. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter